DADATA·ANALYSIS
FREE
company · cik 1157601

MADRIGAL PHARMACEUTICALS, INC.

MDGLNasdaqSIC 2834public
financials · annual · usd2026
Revenue$958.4M
Net income-$288.3M
Total assets$1.26B
Total liabilities$656.9M
Equity$602.7M
LT debt$339.9M
Operating cash-$189.6M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts2